ADC Therapeutics SA: ADC Therapeutics Appoints Mohamed Zaki

ADC Therapeutics SA (NYSE: ADCT) today announced the appointment of industry veteran Mohamed Zaki, MD, PhD, as Chief Medical Officer (CMO), effective January 3, 2023. He will serve on the Company's executive

Related Keywords

Cairo , Al Qahirah , Egypt , United States , New Jersey , Switzerland , London , City Of , United Kingdom , Amanda Loshbaugh , Lausanne Biop , Mary Ann Ondish , Mohamed Zaki , Eugenia Litz , Joseph Camardo , Linkedin , Company On Twitter , Global Head Of Oncology Development At Abbvie , Mitsubishi Tanabe Pharma Corporation , Exchange Commission , Centocor Inc , Company Annual Report On Form , University Of Pennsylvania , Overland Pharmaceuticals , Ain Shams University School Of Medicine , Johnson , Chief Medical Officer , Business Wire , Ameet Mallik , Chief Executive Officer , Vice President Global Head , Oncology Development , Ain Shams University School , San Francisco Bay Area , Private Securities Litigation Reform Act , Swedish Orphan Biovitrum , European Economic Area , Healthcare Royalty Management , Oak Tree , Annual Report , Ann Ondish , Therapeutics , Ppoints , Mohamed , Saki , Chief , Medical , Officer ,